【Molecular composition】：

【CAS NO】：475207-59-1

【source】：Sorafenib

【authentication】：—

【specifications】：FormⅠ/Form Ⅲ

【DMF】：—

【use to】：

Sorafenib is indicated for the treatment of patients with advanced renal cell carcinoma.